Category: Respiratory/Pulmonary
Global Respiratory/Pulmonary
-
The 2025-2030 World Outlook for Cold, Cough, and Sore Throat Medications
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Cold, Cough, and Sore Throat Syrups and Drops
... year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of ... Read More
-
The 2025-2030 World Outlook for Metered-Dose Pulmonary and Respiratory Drug Delivery Systems
... estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. ... Read More
-
The 2025-2030 World Outlook for Generic Inhalation and Nasal Spray Drugs
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Antibiotics for Bovine Respiratory Disease Treatments
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Bronchitis Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Pulmonary Drug Delivery Devices
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Pulmonary-Respiratory Drug Deliveries
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Respiratory Complications Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Respiratory Diagnostics for Tuberculosis
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Respiratory Monitoring Devices
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Pulmonary and Respiratory Drug Deliveries
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
2024 Global Forecast for Lung Cancer Surgery Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
Global Inhalation and Nasal Spray Generic Drugs Market Growth 2024-2030
... 2023. With growing demand in downstream market, the Inhalation and Nasal Spray Generic Drugs is forecast to a readjusted size of US$ 3796.1 million by 2030 with a CAGR of 4.8% during review period. The ... Read More
-
Cephalosporin Drugs Market Share, Size, Trends, Industry Analysis Report, By Generation; By Route of Administration; By Application (Skin Infection, Respiratory Tract Infection, Urinary Tract Infection, Sexually Transmitted Infection, Ear Infection, Others); By Region; Segment Forecast, 2024- 2032
... 2024- 2032 The global Cephalosporin Drugs market size is expected to reach USD 18.52 billion by 2032, according to a new study by Polaris Market Research. The report “Cephalosporin Drugs Market Share, Size, Trends, Industry ... Read More
-
Global Manual Resuscitators Market, By Type (Self-inflating Resuscitator, Flow-inflating Resuscitator, T-piece), By Modality (Disposable, Reusable), By Material (Silicon, PVC, Rubber), By Application (Chronic Obstructive Pulmonary Disease, Cardiopulmonary Arrest, Others), By End User (Hospitals, Out of Hospital, Ambulance Services, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Hospital, Ambulance Services, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Global manual resuscitators market was valued at US$ 540.7 Mn in 2023 and is expected to reach US$ ... Read More
-
2024 Global Pharmaceutical Preparations, Acting On The Respiratory System, For Human Use Products Markets (2030 Outlook)
... market size data globally, regionally and for 46 countries (Wharry Sharpe Research) The Global Products Markets Outlook reports provide product market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), ... Read More
-
Lung Cancer Diagnostics Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Companies Analysis
... according to Renub Research. In modern-day healthcare, lung cancer diagnostics are pivotal in early detection and personalized treatment. Advanced imaging strategies like CT scans and MRI permit particular identification of tumors and metastases, assisting in ... Read More
-
Pulmonary Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028
... Fibrosis, Chronic Bronchitis, And Others), Distribution Channel (Hospital And Retail Pharmacies, E-Commerce, And Others) and geography is expected to grow at a steady CAGR forecast till 2028 owing to the increasing prevalence of pulmonary disorders ... Read More
-
Inhalation And Nasal Spray Generic Drugs Global Market Report 2024
... Patient; Adult Patient; Pediatric Patient4) By End-User: Hospitals; HomecareCovering: Teva Pharmaceuticals Inc.; Sandoz International GmbH; Akorn Operating Company LLC; Cipla Inc.; Apotex Inc. Inhalation And Nasal Spray Generic Drugs Global Market Report 2024 from The ... Read More
-
Idiopathic Pulmonary Fibrosis - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Idiopathic Pulmonary Fibrosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, Vaccines), Distribution Channel - Global Forecast 2024-2030
... USD 1.96 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.58% to reach USD 3.27 billion by 2030. Global Bovine Respiratory Disease Treatment Market FPNV Positioning Matrix The ... Read More
-
Digital Respiratory Devices Market by Product (Sensors & Apps, Smart Inhalers & Nebulizers), Disease Indications (Asthma, COPD, Infectious Diseases), Distribution Channel, End-Use - Global Forecast 2024-2030
... USD 23.45 billion in 2023 and expected to reach USD 30.61 billion in 2024, at a CAGR 30.95% to reach USD 154.87 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
2024 Global: Vaccines Against Sars-Related Coronaviruses "Sars-Cov Species", For Human Medicine Products-Manufacturing Forecast (2030) report
... projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and ... Read More
-
Respiratory Tract Infection Therapeutic Market by Drugs (Antibiotics, Cough Suppressants, Nasal Decongestants), Disease Indication (Lower Respiratory Tract Infection, Upper Respiratory Tract Infection), Distribution Channel - Global Forecast 2024-2030
... was estimated at USD 45.33 billion in 2023 and expected to reach USD 48.83 billion in 2024, at a CAGR 7.80% to reach USD 76.70 billion by 2030. Global Respiratory Tract Infection Therapeutic Market FPNV ... Read More
Research Assistance
